EIF3B‑METTL3 complex promotes cell proliferation, invasion and EGFR/AKT signaling in cervical cancer
Oncology Reports · 2025
DOI: 10.3892/or.2025.8936 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Reports, 2025. Verfasst von Chao Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Changzhou Maternal and Child Health Care Hospital, Changzhou Medical Center, Nanjing Medical University, Changzhou, Jiangsu…. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Eukaryotic Initiation Factor-3, Proto-Oncogene Proteins c-akt, Methyltransferases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecology, Changzhou Maternal and Child Health Care Hospital, Changzhou Medical Center, Nanjing Medical University, Changzhou, Jiangsu 213000, P.R. China.
Zitieren
APA
Zhang, C., Fan, X., Yang, J., & Zhu, P. (2025). EIF3B‑METTL3 complex promotes cell proliferation, invasion and EGFR/AKT signaling in cervical cancer. Oncology Reports. https://doi.org/10.3892/or.2025.8936
Vancouver
Zhang C, Fan X, Yang J, Zhu P. EIF3B‑METTL3 complex promotes cell proliferation, invasion and EGFR/AKT signaling in cervical cancer. Oncology Reports. 2025. doi:10.3892/or.2025.8936
BibTeX
@article{Zhang2025,
author = {Zhang, Chao and Fan, Xiang and Yang, Jia and Zhu, Pengfeng},
title = {EIF3B‑METTL3 complex promotes cell proliferation, invasion and EGFR/AKT signaling in cervical cancer},
journal = {Oncology Reports},
year = {2025},
doi = {10.3892/or.2025.8936}
}
EUVIMED